Neo Ivy Capital Management’s Amdocs DOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-587
Closed -$53.6K 421
2025
Q2
$53.6K Buy
+587
New +$52.5K 0.02% 309
2023
Q3
Sell
-4,833
Closed -$478K 353
2023
Q2
$478K Buy
+4,833
New +$455K 0.25% 132
2022
Q1
Sell
-2
Closed 509
2021
Q4
$0 Buy
+2
New +$150 ﹤0.01% 475
2021
Q3
Sell
-2,556
Closed -$198K 506
2021
Q2
$198K Sell
2,556
-9,290
-78% -$717K 0.2% 185
2021
Q1
$831K Buy
+11,846
New +$895K 0.91% 9
2020
Q4
Sell
-130
Closed -$7K 457
2020
Q3
$7K Buy
+130
New +$7.77K 0.01% 433
2020
Q2
Sell
-11
Closed -$1K 494
2020
Q1
$1K Buy
+11
New +$737 ﹤0.01% 443
2019
Q2
Sell
-26,600
Closed -$1.44M 304
2019
Q1
$1.44M Buy
+26,600
New +$1.5M 0.82% 21

Other funds holding DOX

Neo Ivy Capital Management's DOX Position: Q3 2025 in Review

Neo Ivy Capital Management sold out of Amdocs (DOX) in Q3 2025, closing a stake of 587 shares — an estimated $53.6K sold.

Neo Ivy Capital Management first reported a position in DOX in Q1 2019 and held it in 8 quarters. The position peaked at $1.44M in Q1 2019. 526 funds tracked by Wall St. Rank hold DOX as of Q3 2025.

  • Neo Ivy Capital Management reported no remaining Amdocs position as of Q3 2025 after selling out during the quarter.
  • Neo Ivy Capital Management sold 587 Amdocs shares in Q3 2025, an estimated $53.6K.
  • Neo Ivy Capital Management first reported a position in Amdocs in Q1 2019 and held it in 8 quarters.
  • Neo Ivy Capital Management's Amdocs position peaked at $1.44M in Q1 2019.
  • 526 funds tracked by Wall St. Rank held Amdocs as of Q3 2025.

Based on Neo Ivy Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.